Supernus [SUPN] vs Zoetis [ZTS] Detailed Stock Comparison
Supernus
NASDAQ
Loading...
Zoetis
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Supernus wins in 9 metrics, Zoetis wins in 10 metrics, with 0 ties. Zoetis appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Supernus | Zoetis | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 39.03 | 25.36 | Zoetis |
| Price-to-Book Ratio | 2.37 | 13.14 | Supernus |
| Debt-to-Equity Ratio | 2.99 | 137.01 | Supernus |
| PEG Ratio | 3.51 | 23.24 | Supernus |
| EV/EBITDA | 15.32 | 17.91 | Supernus |
| Profit Margin (TTM) | 9.70% | 27.83% | Zoetis |
| Operating Margin (TTM) | 6.73% | 40.20% | Zoetis |
| EBITDA Margin (TTM) | 6.73% | 40.20% | Zoetis |
| Return on Equity | 6.38% | 52.77% | Zoetis |
| Return on Assets (TTM) | 2.39% | 15.37% | Zoetis |
| Free Cash Flow (TTM) | $171.23M | $2.30B | Zoetis |
| Dividend Yield | N/A | 1.11% | N/A |
| 1-Year Return | 28.34% | -13.42% | Supernus |
| Price-to-Sales Ratio (TTM) | 3.78 | 6.96 | Supernus |
| Enterprise Value | $2.03B | $70.67B | Zoetis |
| EV/Revenue Ratio | 3.05 | 7.53 | Supernus |
| Gross Profit Margin (TTM) | 89.83% | 73.62% | Supernus |
| Revenue per Share (TTM) | $12 | $21 | Zoetis |
| Earnings per Share (Diluted) | $1.15 | $5.81 | Zoetis |
| Beta (Stock Volatility) | 0.74 | 0.88 | Supernus |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Supernus vs Zoetis Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Supernus | 3.60% | 5.13% | 37.37% | 40.07% | 37.33% | 23.20% |
| Zoetis | 1.51% | 1.63% | 3.59% | -3.30% | -5.26% | -3.68% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Supernus | 28.34% | 32.62% | 102.80% | 152.13% | 651.76% | 651.76% |
| Zoetis | -13.42% | -2.05% | -2.11% | 242.11% | 405.06% | 405.06% |
Performance & Financial Health Analysis: Supernus vs Zoetis
| Metric | SUPN | ZTS |
|---|---|---|
| Market Information | ||
| Market Cap | $2.52B | $65.30B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 854,070 | 4,111,510 |
| 90 Day Avg. Volume | 969,440 | 3,459,870 |
| Last Close | $44.88 | $167.10 |
| 52 Week Range | $29.16 - $45.01 | $139.70 - $200.33 |
| % from 52W High | -0.29% | -16.59% |
| All-Time High | $61.25 (Jun 25, 2018) | $249.27 (Dec 27, 2021) |
| % from All-Time High | -26.73% | -32.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | 0.04% |
| Quarterly Earnings Growth | 0.13% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.10% | 0.28% |
| Operating Margin (TTM) | 0.07% | 0.40% |
| Return on Equity (TTM) | 0.06% | 0.53% |
| Debt to Equity (MRQ) | 2.99 | 137.01 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $18.96 | $11.21 |
| Cash per Share (MRQ) | $9.32 | $3.28 |
| Operating Cash Flow (TTM) | $187.06M | $2.93B |
| Levered Free Cash Flow (TTM) | $150.12M | $2.29B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.11% |
| Last 12-Month Dividend | N/A | $1.86 |
Valuation & Enterprise Metrics Analysis: Supernus vs Zoetis
| Metric | SUPN | ZTS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 39.03 | 25.36 |
| Forward P/E | 23.75 | 23.24 |
| PEG Ratio | 3.51 | 23.24 |
| Price to Sales (TTM) | 3.78 | 6.96 |
| Price to Book (MRQ) | 2.37 | 13.14 |
| Market Capitalization | ||
| Market Capitalization | $2.52B | $65.30B |
| Enterprise Value | $2.03B | $70.67B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.05 | 7.53 |
| Enterprise to EBITDA | 15.32 | 17.91 |
| Risk & Other Metrics | ||
| Beta | 0.74 | 0.88 |
| Book Value per Share (MRQ) | $18.96 | $11.21 |
Financial Statements Comparison: Supernus vs Zoetis
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SUPN | ZTS |
|---|---|---|
| Revenue/Sales | $149.82M | $2.22B |
| Cost of Goods Sold | $15.76M | $622.00M |
| Gross Profit | $134.06M | $1.60B |
| Research & Development | $26.93M | $157.00M |
| Operating Income (EBIT) | $-2.60M | $846.00M |
| EBITDA | $25.45M | $991.00M |
| Pre-Tax Income | $-5.83M | $810.00M |
| Income Tax | $6.00M | $179.00M |
| Net Income (Profit) | $-11.83M | $631.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SUPN | ZTS |
|---|---|---|
| Cash & Equivalents | $115.85M | $1.72B |
| Total Current Assets | $687.58M | $5.88B |
| Total Current Liabilities | $281.77M | $3.39B |
| Long-Term Debt | $26.37M | $5.40B |
| Total Shareholders Equity | $1.03B | $4.66B |
| Retained Earnings | $544.60M | $12.38B |
| Property, Plant & Equipment | $0 | $6.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SUPN | ZTS |
|---|---|---|
| Operating Cash Flow | $22.33M | $567.00M |
| Capital Expenditures | $-327,000 | N/A |
| Free Cash Flow | $30.27M | $438.00M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | $-443.00M |
Short Interest & Institutional Ownership Analysis
| Metric | SUPN | ZTS |
|---|---|---|
| Shares Short | 5.08M | 7.85M |
| Short Ratio | 6.80 | 2.67 |
| Short % of Float | 0.13% | 0.02% |
| Average Daily Volume (10 Day) | 854,070 | 4,111,510 |
| Average Daily Volume (90 Day) | 969,440 | 3,459,870 |
| Shares Outstanding | 55.74M | 448.47M |
| Float Shares | 48.90M | 442.37M |
| % Held by Insiders | 0.04% | 0.00% |
| % Held by Institutions | 1.09% | 0.98% |
Dividend Analysis & Yield Comparison: Supernus vs Zoetis
| Metric | SUPN | ZTS |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.86 |
| Last 12-Month Dividend Yield | N/A | 1.11% |
| 3-Year Avg Annual Dividend | N/A | $1.63 |
| 3-Year Avg Dividend Yield | N/A | 0.24% |
| 3-Year Total Dividends | N/A | $4.90 |
| Ex-Dividend Date | N/A | Apr 21, 2025 |